Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules

Kieran D. Lamb, Martha M. Luka, Megan Saathoff, Richard J. Orton, My V. T. Phan, Matthew Cotten, Ke Yuan, David L. Robertson. Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules. PLoS Computational Biology, 20(1), January 2024. [doi]

References

No references recorded for this publication.

Cited by

No citations of this publication recorded.